
    
      PRIMARY OBJECTIVES:

      I. To test the diagnostic performance of PET- MRI in the staging of preoperative high-grade
      rectal cancer patients, defined by T3 stage or higher or N1 stage or higher or presence of
      metastasis, that are referred to PET-CT and MRI.

      II. To test the diagnostic performance of PET-MRI the follow up of colorectal cancer patients
      that are referred to PET-CT with or without a diagnostic MRI request by their physicians.

      SECONDARY OBJECTIVES:

      I. To test different attenuation correction MR sequences and novel diagnostic MR sequences.

      OUTLINE:

      Patients undergo fludeoxyglucose F 18 PET-CT and PET-MRI.
    
  